Publications by authors named "Heidi Mills"

Claim this Profile
M
MUC1 is a potential target for the treatment of acute myeloid leukemia stem cells.
Dina Stroopinsky, Jacalyn Rosenblatt, Keisuke Ito, Heidi Mills, Li Yin

Cancer Res· September 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Vaccination with dendritic cell/tumor fusions following autologous stem cell transplant induces immunologic and clinical responses in multiple myeloma patients.
Jacalyn Rosenblatt, Irit Avivi, Baldev Vasir, Lynne Uhl, Nikhil C Munshi, Heidi Mills

Clin Cancer Res· July 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Lenalidomide enhances anti-myeloma cellular immunity.
Katarina Luptakova, Jacalyn Rosenblatt, Brett Glotzbecker, Heidi Mills, Dina Stroopinsky

Cancer Immunol Immunother· January 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Induction of antitumor immunity ex vivo using dendritic cells transduced with fowl pox vector expressing MUC1, CEA, and a triad of costimulatory molecules (rF-PANVAC).
Baldev Vasir, Corrine Zarwan, Rehan Ahmad, Keith D Crawford, Hassan Rajabi, Heidi Mills

J Immunother· September 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Increased program cell death-1 expression on T lymphocytes of patients with progressive multifocal leukoencephalopathy.
Chen Sabrina Tan, Evelyn Bord, Thomas A Broge, Brett Glotzbecker, Heidi Mills

J Acquir Immune Defic Syndr· July 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Modifications in the nitric acid oxidation of D-glucose.
Tyler N Smith, Kirk Hash, Cara-Lee Davey, Heidi Mills, Holly Williams

Carbohydr Res· March 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
PD-1 blockade by CT-011, anti-PD-1 antibody, enhances ex vivo T-cell responses to autologous dendritic cell/myeloma fusion vaccine.
Jacalyn Rosenblatt, Brett Glotzbecker, Heidi Mills, Baldev Vasir, Dimitrios Tzachanis

J Immunother· June 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Generation of tumor-specific T lymphocytes using dendritic cell/tumor fusions and anti-CD3/CD28.
Jacalyn Rosenblatt, Zekui Wu, Baldev Vasir, Corrine Zarwan, Richard Stone, Heidi Mills

J Immunother· June 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis